David JM - Search Results

1

Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.

Yoshida EJ, Luu M, David JM, Kim S, Mita A, Scher K, Shiao SL, Tighiouart M, Ho AS, Zumsteg ZS. Yoshida EJ, et al. Among authors: david jm. Head Neck. 2018 Jun;40(6):1228-1236. doi: 10.1002/hed.25100. Epub 2018 Feb 8. Head Neck. 2018. PMID: 29417700

2

Predictors of survival in head and neck mucosal melanoma.

Schmidt MQ, David J, Yoshida EJ, Scher K, Mita A, Shiao SL, Ho AS, Zumsteg ZS. Schmidt MQ, et al. Oral Oncol. 2017 Oct;73:36-42. doi: 10.1016/j.oraloncology.2017.08.002. Epub 2017 Aug 10. Oral Oncol. 2017. PMID: 28939074

3

Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.

Zumsteg ZS, Kim S, David JM, Yoshida EJ, Tighiouart M, Shiao SL, Scher K, Mita A, Sherman EJ, Lee NY, Ho AS. Zumsteg ZS, et al. Among authors: david jm. Cancer. 2017 May 1;123(9):1555-1565. doi: 10.1002/cncr.30508. Epub 2016 Dec 21. Cancer. 2017. PMID: 28001302 Free article.

4

Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.

David JM, Ho AS, Luu M, Yoshida EJ, Kim S, Mita AC, Scher KS, Shiao SL, Tighiouart M, Zumsteg ZS. David JM, et al. Cancer. 2017 Oct 15;123(20):3933-3942. doi: 10.1002/cncr.30843. Epub 2017 Jun 22. Cancer. 2017. PMID: 28640546 Free article.

5

Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.

Zumsteg ZS, Luu M, Yoshida EJ, Kim S, Tighiouart M, David JM, Shiao SL, Mita AC, Scher KS, Sherman EJ, Lee NY, Ho AS. Zumsteg ZS, et al. Among authors: david jm. Cancer. 2017 Dec 1;123(23):4583-4593. doi: 10.1002/cncr.30933. Epub 2017 Aug 17. Cancer. 2017. PMID: 28817183 Free PMC article.

6

Outcomes with brachytherapy based dose escalation for gleason 8 versus 9-10 prostate cancer: An NCDB analysis.

David J, Luu M, Lu D, Zumsteg ZS, Sandler H, Kamrava M. David J, et al. Urol Oncol. 2021 Dec;39(12):829.e19-829.e26. doi: 10.1016/j.urolonc.2021.04.014. Epub 2021 May 26. Urol Oncol. 2021. PMID: 34049784

7

Facility Volume and Survival in Nasopharyngeal Carcinoma.

Yoshida EJ, Luu M, David JM, Kim S, Mita A, Scher K, Shiao SL, Tighiouart M, Lee NY, Ho AS, Zumsteg ZS. Yoshida EJ, et al. Among authors: david jm. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):408-417. doi: 10.1016/j.ijrobp.2017.09.038. Epub 2017 Sep 28. Int J Radiat Oncol Biol Phys. 2018. PMID: 29100787

8

Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers.

David JM, Kim S, Placencio-Hickok VR, Torosian A, Hendifar A, Tuli R. David JM, et al. Adv Radiat Oncol. 2018 Nov 9;4(2):302-313. doi: 10.1016/j.adro.2018.10.006. eCollection 2019 Apr-Jun. Adv Radiat Oncol. 2018. PMID: 31011675 Free PMC article.

9

Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms.

Guan M, He I, Luu M, David J, Gong J, Placencio-Hickok VR, Reznik RS, Tuli R, Hendifar AE. Guan M, et al. Adv Radiat Oncol. 2019 Apr 10;4(3):513-519. doi: 10.1016/j.adro.2019.03.014. eCollection 2019 Jul-Sep. Adv Radiat Oncol. 2019. PMID: 31360808 Free PMC article.

10

Duration of therapy for locally advanced pancreatic cancer: Does it matter?

Tuli R, David J, Lobaugh S, Zhang Z, O'Reilly EM. Tuli R, et al. Cancer Med. 2020 Jul;9(13):4572-4580. doi: 10.1002/cam4.3081. Epub 2020 May 5. Cancer Med. 2020. PMID: 32368871 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters